Angiotech Pharmaceuticals (Vancouver, British Columbia), a specialty pharmaceutical company focusing on drug-coated medical devices and biomaterials, said it has licensed a portfolio of biomaterial, drug delivery and medical device technologies from Poly-Med (Anderson, South Carolina).